BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27470546)

  • 21. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment.
    Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ
    Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of the migration and invasion is mediated by triptolide in B16F10 mouse melanoma cells through the NF-kappaB-dependent pathway.
    Jao HY; Yu FS; Yu CS; Chang SJ; Liu KC; Liao CL; Ji BC; Bau DT; Chung JG
    Environ Toxicol; 2016 Dec; 31(12):1974-1984. PubMed ID: 26420756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway.
    Zhu W; Ou Y; Li Y; Xiao R; Shu M; Zhou Y; Xie J; He S; Qiu P; Yan G
    Mol Pharmacol; 2009 Apr; 75(4):812-9. PubMed ID: 19158360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Triptolide induces oxidative stress and apoptosis and activates PIK3/Akt signaling pathway in TM4 sertoli cells].
    Wang H; Chen L; Ye XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):607-612. PubMed ID: 30122757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
    Lundgren K; Zhang H; Brekken J; Huser N; Powell RE; Timple N; Busch DJ; Neely L; Sensintaffar JL; Yang YC; McKenzie A; Friedman J; Scannevin R; Kamal A; Hong K; Kasibhatla SR; Boehm MF; Burrows FJ
    Mol Cancer Ther; 2009 Apr; 8(4):921-9. PubMed ID: 19372565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways.
    Mujumdar N; Mackenzie TN; Dudeja V; Chugh R; Antonoff MB; Borja-Cacho D; Sangwan V; Dawra R; Vickers SM; Saluja AK
    Gastroenterology; 2010 Aug; 139(2):598-608. PubMed ID: 20434451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking NF-κB and Akt by Hsp90 inhibition sensitizes Smac mimetic compound 3-induced extrinsic apoptosis pathway and results in synergistic cancer cell death.
    Bai L; Xu S; Chen W; Li Z; Wang X; Tang H; Lin Y
    Apoptosis; 2011 Jan; 16(1):45-54. PubMed ID: 20862547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triptolide suppresses growth and hormone secretion in murine pituitary corticotroph tumor cells via NF-kappaB signaling pathway.
    Li R; Zhang Z; Wang J; Huang Y; Sun W; Xie R; Hu F; Lei T
    Biomed Pharmacother; 2017 Nov; 95():771-779. PubMed ID: 28892788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triptolide ameliorates fine particulate matter-induced podocytes injury via regulating NF-κB signaling pathway.
    Wan Q; Liu Z; Yang M; Deng P; Tang N; Liu Y
    BMC Mol Cell Biol; 2020 Feb; 21(1):4. PubMed ID: 32013860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triptolide, histone acetyltransferase inhibitor, suppresses growth and chemosensitizes leukemic cells through inhibition of gene expression regulated by TNF-TNFR1-TRADD-TRAF2-NIK-TAK1-IKK pathway.
    Park B; Sung B; Yadav VR; Chaturvedi MM; Aggarwal BB
    Biochem Pharmacol; 2011 Nov; 82(9):1134-44. PubMed ID: 21820422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
    El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
    Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
    Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
    Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Triptolide induces autophagy of ovarian granulosa cells via PI3K/AKT/m TOR pathway].
    Bai J; Wu YK; Wu KM; Zhu HL; Li N; Chen M; Liu LX
    Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3429-3434. PubMed ID: 31602905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsp70 inhibition potentiates radicicol-induced cell death in anaplastic thyroid carcinoma cells.
    Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
    Anticancer Res; 2014 Sep; 34(9):4829-37. PubMed ID: 25202064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
    Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
    Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
    Li H; Jin X; Zhang Z; Xing Y; Kong X
    Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triptolide induces apoptosis of PMA-treated THP-1 cells through activation of caspases, inhibition of NF-κB and activation of MAPKs.
    Park SW; Kim YI
    Int J Oncol; 2013 Oct; 43(4):1169-75. PubMed ID: 23900299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
    Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.